CWC
AVNS

Carolinas Wealth Consulting’s Avanos Medical AVNS Stock Holding History

Carolinas Wealth Consulting’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-321
Closed -$321 – 1044
2023
Q4 		$321 Hold
321
– – ﹤0.01% 965
2023
Q3 		$321 Hold
321
– – ﹤0.01% 980
2023
Q2 		$321 Hold
321
– – ﹤0.01% 1040
2023
Q1 		$321 Hold
321
– – ﹤0.01% 1039
2022
Q4 		$321 Hold
321
– – ﹤0.01% 1038
2022
Q3 		$0 Hold
321
– – ﹤0.01% 878
2022
Q2 		$0 Buy
+321
New +$9.22K ﹤0.01% 886

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Carolinas Wealth Consulting's AVNS Position: Q1 2024 in Review

Carolinas Wealth Consulting sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 321 shares — an estimated $321 sold.

Carolinas Wealth Consulting first reported a position in AVNS in Q2 2022 and held it in 7 quarters. The position peaked at $321 in Q4 2023. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • Carolinas Wealth Consulting reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 321 Avanos Medical shares in Q1 2024, an estimated $321.
  • Carolinas Wealth Consulting first reported a position in Avanos Medical in Q2 2022 and held it in 7 quarters.
  • Carolinas Wealth Consulting's Avanos Medical position peaked at $321 in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2024, filed 15 May 2024.